Stay updated on ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial
Sign up to get notified when there's something new on the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page.

Latest updates to the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page
- Check3 days agoChange DetectedThe footer's site revision identifier changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check10 days agoChange DetectedA notice was added about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference0.6%

- Check17 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check24 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check45 days agoChange DetectedThe study record history now includes a new Revision: v3.7.0 entry and removes the previous Revision: v3.6.6 entry, updating the revision history to reflect the latest state of the record.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision entry (v3.6.6) was added to the study's record history. The previous revision (v3.6.5) was removed from the list.SummaryDifference0.1%

Stay in the know with updates to ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page.